H. Lawrence Culp, Jr.
Larry Culp recently stepped down as Danaher Corporation’s Chief Executive Officer and President to become a Senior Advisor following a nearly 14-year run during which revenues and market capitalization increased approximately five-fold to nearly $20 billion and $50 billion, respectively, while at the same time driving shareholder returns five times that of the S&P 500 Index. He also played a key role in the evolution of the Danaher Business System, the common operating philosophy and model deployed across Danaher.
During Mr. Culp’s tenure, international sales expanded from approximately 40% of total revenues to almost 60% today and the company deployed approximately $25 billion for strategic acquisitions. Mr. Culp drove the establishment and growth of Danaher’s health care platforms in clinical diagnostics, life sciences and dental.
Investors and analysts alike consistently ranked him as one of the top CEO’s in the annual Institutional Investor surveys. Harvard Business Review recently named Mr. Culp one of the Top 50 CEO’s in the world.
He joined Danaher in 1990 from Veeder-Root, a Danaher subsidiary, where he became President in April 1993. In 1995, he was appointed Group Executive and Corporate Officer, with responsibility for Danaher’s Environmental and Electronic Test and Measurement platforms.
Mr. Culp also served as President of Fluke and Fluke Networks. He became an Executive Vice President of Danaher in 1999, Chief Operating Officer in 2000, and President and CEO in May 2001.
He recently joined the faculty of the Harvard Business School as Senior Lecturer focused on strategy and general management.
Mr. Culp is currently chair of the Board of Visitors and Governors of Washington College, on the Board of Trustees of Wake Forest University and formerly chair of the Board of Trustees for Potomac School. He served as a Non-Executive Director at GlaxoSmithKline PLC.
Mr. Culp holds a B.A. from Washington College and MBA from Harvard Business School.